Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › CA › Burbank › NPI 1669650529
Physician

Mark Schlesinger, M.D., a Professional Corporation

Mark Schlesinger, M.D., a Professional Corporation was paid $65K by Medicaid between Jan 2018 and Sep 2023, across 4 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 99% of everything it billed.

33Billing provider infoMARK SCHLESINGER, M.D., A PROFESSIONAL CORPORATION
BURBANK, CA 91506
33aNPI1669650529assigned 02/03/2008
28Total paid$65K
24GClaims2,519
24DCodes billed4
24AFirst – last monthJan 2018 – Sep 2023
Compared with peers

Next to other Pain Medicine (Anesthesiology) Physician providers in California

Rank by total paid#51 of 125
Median peer was paid$24K
This provider vs. median2.7×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$2.0K$4.0K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
2018419$4K
2019784$10K
2020485$18K
2021338$13K
2022293$13K
2023200$6K
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99214 Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 99% 2,228 1,996 $65K
J1040 Injection, methylprednisolone acetate, 80 mg <1% 78 68 $156.20
62323 <1% 33 30 $147.58
Q9966 Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml <1% 180 157 $26.05

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialSCHLESINGER, MARK (PRESIDENT)